Memphis scientists instrumental in new, landmark COVID drug
The next possible landmark COVID drug is so rich in Memphis DNA that if approved by the FDA, patent royalty checks will immediately flow to town. Plus, it’s in capsule form, taken once a day for 21 days. It does not need to be refrigerated and can be shipped easily and inexpensively around the world.